Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care

BACKGROUND: To assess the symptomatic and cost burden among patients initiating long-acting bronchodilator (LABD) therapy and impact of adherence on healthcare resource use and costs. METHODS: This retrospective cohort study identified patients with COPD who were newly prescribed a LABD (long-acting...

Descripción completa

Detalles Bibliográficos
Autores principales: Punekar, Yogesh Suresh, Landis, Sarah H, Wurst, Keele, Le, Hoa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647637/
https://www.ncbi.nlm.nih.gov/pubmed/26572740
http://dx.doi.org/10.1186/s12931-015-0295-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647637/
https://www.ncbi.nlm.nih.gov/pubmed/26572740
http://dx.doi.org/10.1186/s12931-015-0295-2

Ejemplares similares